PSYCH up2date, Table of Contents PSYCH up2date 2016; 10(03): 195-210DOI: 10.1055/s-0042-100900 Essstörungen, somatische Belastungsstörungen, Schlafstörungen und sexuelle Funktionsstörungen Psychodermatologie und geschlechtsspezifische Aspekte chronischer Hauterkrankungen Gerhard Schmid-Ott , Tatjana Steen , Scott Stock Gissendanner Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur 1 Gieler U. Unsere Haut fühlt mit uns. In: Taube KM, Rapp G, Seikowski K, Gieler U. Hrsg. Die Haut und die Sprache der Seele. Munderfing: fischer & gann; 2015: 15-23 2 Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007; 9: 203-213 3 Harth W. Psychiatrische Erkrankungen und traumatisierter Patient. In: Plewig G, Landthaler M, Burgdorf WHC. et al., Hrsg. Braun-Falco’s Dermatologie, Venerologie und Allerologie. 6. Aufl. Berlin: Springer; 2015 4 Deutsche Dermatologische Gesellschaft, Deutsches Kollegium für Psychosomatische Medizin, Deutsche Gesellschaft für Psychotherapeutische Medizin, Allgemeine Ärztliche Gesellschaft für Psychotherapie. S2-Leitlinie Psychosomatische Dermatologie (Psychodermatologie). AWMF-Registernummer: 013/024. Gültig bis 31.10.2010. In Überarbeitung. Berlin: Deutsche Dermatologische Gesellschaft; 2006 5 Schneider G, Gieler U. Die Haut als Spiegel der Seele: Psychosomatische Dermatologie – aktueller Forschungsstand. Z Psychom Med Psychother 2001; 47: 307-331 6 Deutsche Rentenversicherung Bund. Leitlinie zur Rehabilitationsbedürftigkeit bei Krankheiten der Haut. Berlin: DRV Bund; 2012 7 Deutsche Dermatologische Gesellschaft. S2k-Leitlinie Behandlung der Akne. AWMF-Registernr. 013/026. Gültig bis Dezember 2015. Berlin: Deutsche Dermatologische Gesellschaft; 2011 8 Brasch J, Becker D, Aberer W. et al. Leitlinie Kontaktekzem. Allergo J Int 2015; 23: 126-139 9 Nast A, Boehncke W, Mrowietz U. et al. S3-Leitlinie zur Therapie der Psoriasis vulgaris. AWMF-Registernr. 013/001. Gültig bis Januar 2016.. Berlin: Deutsche Dermatologische Gesellschaft; 2011 10 Reinholz M, Tietze J, Kilian K. et al. S1-Leitlinie Rosazea. AWMF-Registernr. 013/065. Gültig bis April 2017.. Berlin: Deutsche Dermatologische Gesellschaft; 2015 11 Dalgard FJ, Gieler U, Tomas-Aragones L. et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135: 984-991 12 World Health Organization. Internationale Klassifikation der Funktionsfähigkeit, Behinderung und Gesundheit ICF. Genf: World Health Organization; 2005 13 Niederauer HH, Schmid-Ott G, Buhles N. Die Internationale Klassifikation der Funktionsfähigkeit, Behinderung und Gesundheit (ICF) in der Dermatologischen Rehabilitation. Konzept, Anwendung, Perspektive. Hautarzt 2005; 56: 631-636 14 Raap U, Werfel T, Jaeger B. et al. Atopische Dermatitis und psychischer Stress. Hautarzt 2003; 54: 925-929 15 Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425-429 16 Tur E. Physiology of the skin – differences between women and men. Clin Dermatol 1997; 15: 5-16 17 Koblenzer CS. The emotional impact of chronic and disabling skin disease: a psychoanalytic perspective. Dermatol Clin 2005; 23: 619-627 18 Perrott SB, Murray AH, Lowe J. et al. The personal-group discrimination discrepancy in persons living with psoriasis. Basic and Applied Social Psychology 2000; 22: 57-67 19 Picardi A, Abeni D, Melchi CF. et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991 20 Picardi A, Abeni D, Renzi C. et al. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol 2001; 81: 410-414 21 Koblenzer CS. Psychodermatology of women. Clin Dermatol 1997; 15: 127-141 22 Saitta P, Keehan P, Yousif J. et al. An update on the presence of psychiatric comorbidities in acne patients. Part 1: overview of prevalence. Cutis 2011; 88: 33-40 23 Aktan S, Ozmen E, Sanli B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998; 197: 230-234 24 Skroza N, Tolino E, Proietti I. et al. Women and acne: any difference from males? A review of literature. G Ital Dermatol Venereol 2016; 151: 87-92 25 Saitta P, Keehan P, Yousif J. et al. An update on the presence of psychiatric comorbidities in acne patients. Part 2: Depression, anxiety, and suicide. Cutis 2011; 88: 92-97 26 Gupta MA, Gupta AK, Schork NJ. Psychosomatic study of self-excoriative behavior among male acne patients: preliminary observations. Int J Dermatol 1994; 33: 846-848 27 Tucker P. Bald is beautiful? The psychosocial impact of alopecia areata. J Health Psychol 2009; 14: 142-151 28 Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol 2015; 8: 397-403 29 Bundesarbeitsgemeinschaft für Rehabilitation. Arbeitshilfe für die Rehabilitation von Menschen mit allergischen Hauterkrankungen. Frankfurt/M: BAR; 2013 30 Mina S, Jabeen M, Singh S. et al. Gender differences in depression and anxiety among atopic dermatitis patients. Indian J Dermatol 2015; 60: 211 31 Annesi-Maesano I, Beyer A, Marmouz F. et al. Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? Results of a large-scale cross-sectional study in a French population. Br J Dermatol 2006; 154: 1128-1136 32 Dieris-Hirche J, Gieler U, Kupfer JP. et al. Suizidgedanken, Angst und Depression bei erwachsenen Neurodermitikern. Hautarzt 2009; 60: 641-646 33 Hashiro M, Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci 1997; 14: 63-67 34 Saunes M, Smidesang I, Holmen TL. et al. Atopic dermatitis in adolescent boys is associated with greater psychological morbidity compared with girls of the same age: the Young-HUNT study. Br J Dermatol 2007; 156: 283-288 35 Hashizume H, Takigawa M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006; 6: 335-339 36 Cheng CM, Hsu JW, Huang KL. et al. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord 2015; 178: 60-65 37 Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999; 140: 268-272 38 Leweke F, Bausch S. Alexithymie und Krankheit – Zusammenhänge mit somatischen, psychosomatischen und psychischen Krankheiten. In: Grabe HJ, Rufer M. Hrsg. Alexithymie: Eine Störung der Affektregulation Konzepte, Klinik und Therapie. Bern: Huber; 2009: 127-148 39 Barbosa F, Freitas J, Barbosa A. Chronic idiopathic urticaria and anxiety symptoms. J Health Psychol 2011; 16: 1038-1047 40 Hashiro M, Okumura M. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria. J Dermatol Sci 1994; 8: 129-135 41 Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990; 123: 769-774 42 Boehm D, Schmid-Ott G, Finkeldey F. et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis 2012; 67: 184-192 43 Kouris A, Armyra K, Christodoulou C. et al. Quality of life, anxiety, depression and obsessive-compulsive tendencies in patients with chronic hand eczema. Contact Dermatitis 2015; 72: 367-370 44 Yu M, Han TY, Lee JH. et al. The Quality of life and depressive mood among Korean patients with hand eczema. Ann Dermatol 2012; 24: 430-437 45 Niemeier V, Nippesen M, Kupfer J. et al. Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care?. Br J Dermatol 2002; 146: 1031-1037 46 Thyssen JP, Johansen JD, Linneberg A. et al. The epidemiology of hand eczema in the general population – prevalence and main findings. Contact Dermatitis 2010; 62: 75-87 47 Braganca GM, Lima SO, Pinto Neto AF. et al. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis. An Bras Dermatol 2014; 89: 230-235 48 Gross KM, Schote AB, Schneider KK. et al. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLoS One 2014; 9: e92412 49 Uguz F, Kucuk A, Cicek E. et al. Mood, anxiety, and personality disorders in patients with systemic lupus erythematosus. Compr Psychiatry 2013; 54: 341-345 50 Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 822-829 51 Kheirandish M, Faezi ST, Paragomi P. et al. Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients. Mod Rheumatol 2015; 25: 405-409 52 Tay SH, Cheung PP, Mak A. Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus. Lupus 2015; 24: 1392-1399 53 Sundquist K, Li X, Hemminki K. et al. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Arch Gen Psychiatry 2008; 65: 501-507 54 Erim Y, Loquai C, Schultheis U. et al. Anxiety, posttraumatic stress, and fear of cancer progression in patients with melanoma in cancer aftercare. Onkologie 2013; 36: 540-544 55 Brandberg Y, Mansson-Brahme E, Ringborg U. et al. Psychological reactions in patients with malignant melanoma. Eur J Cancer 1995; 31A: 157-162 56 Konda D, Chandrashekar L, Rajappa M. et al. Serotonin and interleukin-6: Association with pruritus severity, sleep quality and depression severity in Prurigo nodularis. Asian J Psychiatr 2015; 17: 24-28 57 Schneider G, Hockmann J, Stumpf A. Psychosomatische Aspekte der Prurigo nodularis. Hautarzt 2014; 65: 704-708 58 Schmid-Ott G. Causality for depression and psoriasis is a sex-specific two-way process. Br J Dermatol 2015; 173: 891 59 Golpour M, Hosseini SH, Khademloo M. et al. Depression and anxiety disorders among patients with psoriasis: A hospital-based case-control study. Dermatol Res Pract 2012; 2012: 381905 60 Janowski K, Steuden S, Pietrzak A. et al. Social support and adaptation to the disease in men and women with psoriasis. Arch Dermatol Res 2012; 304: 421-432 61 Böhm D, Stock Gissendanner S, Snitjer K. et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol 2013; 27: 220-226 62 Gupta MA, Schork NJ, Gupta AK. et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-732 63 Dommasch ED, Li T, Okereke OI. et al. Risk of depression in women with psoriasis: a cohort study. Br J Dermatol 2015; 173: 975-980 64 Dominguez PL, Han J, Li T. et al. Depression and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol 2013; 27: 1163-1167 65 Devrimci-Ozguven H, Kundakci TN, Kumbasar H. et al. The depression, anxiety, life satisfaction, and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-271 66 Bangemann K, Schulz W, Wohlleben J. et al. Depression und Angststörung bei Psoriasispatienten: Schutz- und Risikofaktoren. Hautarzt 2014; 65: 1056-1061 67 Esposito M, Saraceno R, Giunta A. et al. An Italian study on psoriasis and depression. Dermatology 2006; 212: 123-127 68 Korkoliakou P, Christodoulou C, Kouris A. et al. Alexithymia, anxiety and depression in patients with psoriasis: a case-control study. Ann Gen Psychiatry 2014; 13: 38 69 Remrod C, Sjostrom K, Svensson A. Psychological differences between early- and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. Br J Dermatol 2013; 169: 344-350 70 Gupta MA, Gupta AK, Chen SJ. et al. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey – Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol 2005; 153: 1176-1181 71 Su D, Drummond PD. Blushing propensity and psychological distress in people with rosacea. Clin Psychol Psychother 2012; 19: 488-495 72 Böhm D, Schwanitz P, Stock Gissendanner S. et al. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med 2014; 19: 586-591 73 Abram K, Silm H, Maaroos HI. et al. Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea. Acta Derm Venereol 2009; 89: 488-491 74 Kostopoulou P, Jouary T, Quintard B. et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol 2009; 161: 128-133 75 Al-Harbi M. Prevalence of depression in vitiligo patients. Skinmed 2013; 11: 327-330 76 Sampogna F, Raskovic D, Guerra L. et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol 2008; 159: 351-359 77 Sangma LN, Nath J, Bhagabati D. Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-east India. Indian J Dermatol 2015; 60: 142-146 78 Gieler U. Ich schäme mich meiner Haut. In: Taube KM, Rapp G, Seikowski K, Gieler U. Hrsg. Die Haut und die Sprache der Seele. Munderfing: fischer & gann; 2015: 34-51 79 Schmid-Ott G, Jäger B, Künsebeck H. et al. Entwicklung des „Fragebogens zum Erleben von Hautbeschwerden“ (FEH): Faktorenanalyse und Untersuchung von Prädiktoren für das Krankheitserleben von Psoriasis-Patienten. Z Klin Psychologie, Psychiatrie und Psychotherapie 1998; 46: 330-343 80 Perrott SB, Murray AH, Lowe J. et al. The psychosocial impact of psoriasis: physical severity, quality of life, and Stigmatization. Physiol Behav 2000; 70: 567-571 81 Schmid-Ott G, Künsebeck HW, Jäger B. et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 2005; 85: 27-32 82 Sampogna F, Tabolli S, Abeni D. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 2007; 157: 508-513 83 Schmid-Ott G, Burchard R, Niederauer HH. et al. Stigmatisierungsgefühl und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis. Hautarzt 2003; 54: 852-857 84 Schmid-Ott G, Künsebeck HW, Jecht E. et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol 2007; 21: 456-461 85 Schmid-Ott G. Dermatologie. In: Adler R, Herzog W, Joraschky P. et al., Hrsg. Uexküll – Psychosomatische Medizin – Theoretische Modelle und klinische Praxis. 7. Aufl. München: Urban & Fischer; 2011: 1118-1126 86 Hertl M, Wolf H. Einführung. In: Plewig G, Landthaler M, Burgdorf WHC. et al., Hrsg. Braun-Falco’s Dermatologie, Venerologie und Allergologie. 6. Aufl. Berlin: Springer; 2015 87 Rapp G. Gibt es Pillen für Hautprobleme? Psychopharmaka in der Hautarztpraxis. In: Taube KM, Rapp G, Seikowski K, Gieler U. Hrsg. Die Haut und die Sprache der Seele. Munderfing: fischer & gann; 2015: 261-274 88 Wehrmann J. Chronischer Juckreiz. In: Taube KM, Rapp G, Seikowski K, Gieler U. Hrsg. Die Haut und die Sprache der Seele. Munderfing: fischer & gann; 2015: 226-231 89 Breuer K, John SM, Finkeldey F. et al. Tertiary individual prevention improves mental health in patients with severe occupational hand eczema. J Eur Acad Dermatol Venereol 2015; 29: 1724-1731 90 Schmid-Ott G, Böhm D, Stock Gissendanner S. Patient considerations in the management of mental stress in psoriasis. Patient Intelligence 2012; 4: 41-50 91 Shimanoe C, Otsuka Y, Hara M. et al. Gender-specific associations of perceived stress and coping strategies with C-reactive protein in middle-aged and older men and women. Int J Behav Med 2014; 21: 821-832 92 Lehto US, Ojanen M, Dyba T. et al. Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res 2007; 63: 9-15 93 Hausteiner-Wiehle C, Schäfert R, Häuser W. et al. S3-Leitlinie Umgang mit Patienten mit nicht-spezifischen, funktionellen und somatoformen Körperbeschwerden. AWMF-Reg.-Nr. 051-001. Gültig bis April 2017.. Stuttgart: Schattauer; 2012
